文献速递治疗药物监测与药物基因组学特殊人群用药药物不良反应与药物警戒

重症儿童与新生儿万古霉素常见剂量不足

Vancomycin is commonly under-dosed in critically ill children and neonates.
PubMed 文献 · Br J Clin Pharmacol · 2019-08-30

本研究回顾性分析了10个月内某三级儿科与新生儿重症监护病房中115例患儿接受的126个静脉万古霉素疗程。仅30%的疗程在初始稳态谷浓度时达到10-20 mg/L的目标浓度,且浓度不达标时仅56%调整了剂量。万古霉素相关肾毒性发生率为8%,建议新生儿(纠正胎龄<35周)至少30 mg/kg/日、年长儿至少50 mg/kg/日,并优化TDM流程。

要点

  • 仅30%的初始稳态谷浓度达标(10-20 mg/L),剂量不足常见。
  • 浓度不达标时仅56%的疗程进行了剂量调整。
  • 纠正胎龄<35周新生儿需≥30 mg/kg/日,年长儿需≥50 mg/kg/日。

核心结论

  • 重症儿童和新生儿万古霉素常见剂量不足,需个体化给药并优化TDM。

研究设计与样本

  • 回顾性研究,纳入某三级儿科与新生儿重症监护病房10个月内接受静脉万古霉素且至少有一次稳态TDM血样的115例患儿,共126个疗程。

主要发现

  • 126个疗程中仅38个(30%)初始稳态谷浓度达到10-20 mg/L目标范围。
  • 88个初始谷浓度不在目标范围的疗程中,仅49个(56%)进行了剂量调整。
  • 万古霉素相关肾毒性发生于10/126(8%)个疗程,未发生红人综合征。

关键数值与推荐

  • 目标谷浓度为10-20 mg/L。
  • 纠正胎龄<35周的新生儿最低剂量需≥30 mg/kg/日以达到目标浓度。
  • 年长儿最低剂量需≥50 mg/kg/日以达到目标浓度。

临床怎么用

  • 在缺乏贝叶斯模型指导给药时,肾功能正常的新生儿(纠正胎龄<35周)可考虑经验性万古霉素至少30 mg/kg/日。
  • 肾功能正常的年长儿可考虑经验性万古霉素至少50 mg/kg/日。
  • 应通过制定方案(最好嵌入电子病历)来优化TDM实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Vancomycin is frequently used in critically ill children in whom the drug pharmacokinetics are significantly altered as a result of changes in renal clearance and volume of distribution. Therapeutic drug monitoring (TDM) is recommended to achieve vancomycin trough concentrations between 10 and 20 mg/L. In this study we reviewed vancomycin dosing, TDM and treatment outcomes in paediatric and neonatal intensive care unit patients. METHODS: We reviewed the medical records of all patients receiving intravenous vancomycin in a tertiary paediatric and neonatal intensive care unit over a 10-month period. Demographic, vancomycin dosing, TDM and drug-related adverse effects data were collected. RESULTS: In total, 115 children received 126 courses of vancomycin and had at least 1 TDM blood sample taken at steady state. In only 38/126 (30%) courses was the target concentration (10-20 mg/L) achieved at the initial steady state trough sample. Of the 88 courses that had initial trough concentrations outside the target range, the dose was adjusted in only 49 (56%). Overall, minimum doses of 30 mg/kg/day in neonates with a corrected gestational age of <35 weeks, and 50 mg/kg/day in older children, were required to achieve target vancomycin concentrations. Vancomycin-attributable nephrotoxicity occurred in 10/126 (8%) courses and there were no episodes of red man syndrome. CONCLUSION: In critically ill children, individualised dosing is needed. In the absence of Bayesian model-based dosing, in children with normal renal function, empiric vancomycin doses of at least 30 mg/kg/day in neonates of <35 weeks corrected gestational age, and 50 mg/kg/day in older children, should be considered. Optimisation of TDM practices through the development of protocols, ideally built into electronic medical records, should be considered.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Sosnin N, Curtis N, Cranswick N, et al. Vancomycin is commonly under-dosed in critically ill children and neonates. Br J Clin Pharmacol. 2019. PMID: 31378957. doi:10.1111/bcp.14084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。